Pharmanutra S.p.A.

Milan Stock Exchange PHN.MI

Pharmanutra S.p.A. EBITDA Margin for the year ending December 31, 2023: 26.26%

Pharmanutra S.p.A. EBITDA Margin is 26.26% for the year ending December 31, 2023, a -11.03% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Pharmanutra S.p.A. EBITDA Margin for the year ending December 31, 2022 was 29.51%, a 4.85% change year over year.
Pharmanutra S.p.A. EBITDA Margin for the year ending December 31, 2021 was 28.15%, a 9.01% change year over year.
Pharmanutra S.p.A. EBITDA Margin for the year ending December 31, 2020 was 25.82%, a 7.52% change year over year.
Pharmanutra S.p.A. EBITDA Margin for the year ending December 31, 2019 was 24.02%, a -9.35% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	112
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Cosmetics Dairy & Milk Drugstores & Retail Pharmacies Personal Care Pet Food Snack Foods

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Key trends

Past 5 years